9 June, 2026
Webinar
Pleural disease webinar series: session five

Mastering pleural medicine: a practical webinar series | Session five: Management of pleural diseases part two – Malignant pleural effusion: treatment for pulmonologists 9 June, 2026 from 17:00–18:00 CEST This ERS webinar, chaired by Dr Georgia Hardavella and Prof. Sotirios Zarogiannis, will cover: Patient perspective: Quality of life and patient recorded outcome measures (PROMS). Inpatient management: Talc pleurodesis or something else – what, when and how? Outpatient management: Indwelling pleural catheter alone – what is to be faced?

Find out more and register

11–13 June, 2026
Skills course
Rigid bronchoscopy

Thursday, June 11, 2026 | Optimizing Patient Outcomes

Recent Advancements in Chemoradiation Strategies for Locally Advanced Cervical Cancer

CME-Register-button

BPMN User Tasks for Humans and AI Agents

June 11, 2026 09:30 AM

BPMN user tasks are evolving beyond human-only work. Modern workflow applications can assign tasks to humans, AI agents, or AI agents operating under human supervision within the same orchestrated process. This webinar explores practical approaches for designing BPMN user tasks across different performer models. Through live demonstrations, we will showcase various task assignment strategies, notifications, dynamic interactions, attended tasks and human review patterns that enable collaboration between humans and AI agents.Attendees will learn how to model explicit responsibility, supervision, and handoff patterns between humans and AI agents while maintaining transparency, governance, and execution control within BPMN workflows. Whether you are building human-centric workflows or introducing AI agents into operational processes, this session will demonstrate how BPMN provides the transparency, governance, and execution control needed to coordinate work across both human and AI performers.

https://streamyard.com/watch/njFYZG42sZgJ

Webinar

Advancing Medical Research with EBSCO Platform Enhancements
June 11, 2026 | 1:00 p.m. ET

In this webinar, EBSCO product experts will demonstrate updates that help streamline the research experience across EBSCOhost and EBSCO Discovery Service, including enhancements to:

Search history and saved search workflows
Bulk actions and record management
Result filtering and navigation
Search set management for complex research strategies
Overall usability and workflow efficiency
Whether your users conduct systematic reviews, advanced literature searches or ongoing clinical research, this session will provide a practical overview of enhancements that can help simplify common pain points and support more effective research experiences.

Speakers
head shot of Kathryn Vela

Kathryn Vela, BS, MLIS
Senior Customer Training Specialist

Kathryn has 10 years of experience as a medical librarian in hospital, corporate, and research environments, and uses her experience to educate people about effective information retrieval in engaging and innovative ways.

Heather White

Heather White, MLS
Senior Product Manager

Heather is a third-generation librarian with 17 years of experience in academic libraries. Now, as a Senior Product Manager at EBSCO, she focuses on enhancing advanced search workflows and addressing the unique needs of medical libraries.

Register: https://more.ebsco.com/WWE-2026-06-11-WBN-Advancing-Med-Research-Platform-3959150_Advancing-Medical-Research-with-EBSCO-Platform-Enhancements.html

Advancing Medical Research with EBSCO Platform Enhancements June 11, 2026 | 1:00 p.m. ET

Register

About

In this webinar, EBSCO product experts will demonstrate updates that help streamline the research experience across EBSCOhost and EBSCO Discovery Service, including enhancements to: Search history and saved search workflows Bulk actions and record management Result filtering and navigation Search set management for complex research strategies Overall usability and workflow efficiency Whether your users conduct systematic reviews, advanced literature searches or ongoing clinical research, this session will provide a practical overview of enhancements that can help simplify common pain points and support more effective research experiences.

Speakers

Kathryn Vela, BS, MLIS Senior Customer Training Specialist Kathryn has 10 years of experience as a medical librarian in hospital, corporate, and research environments, and uses her experience to educate people about effective information retrieval in engaging and innovative ways.

Heather White  Heather White, MLS Senior Product Manager Heather is a third-generation librarian with 17 years of experience in academic libraries. Now, as a Senior Product Manager at EBSCO, she focuses on enhancing advanced search workflows and addressing the unique needs of medical libraries.

Register

Journal Club – COPD heterogeneity: new biological insights for clinical practice 11 June, 2026 from 17:00–18:00 CEST This ERS Journal Club webinar, chaired by Dr Niki L. Reynaert and Dr Theodore Kapellos, will feature two recent studies: Epigenetic Dysregulation of IRF9 Drives Excessive Interferon Signaling in COPD, Dr Maria Llamazares Prada Aberrant Cellular Communities Underlying Disease Heterogeneity in Chronic Obstructive Pulmonary Disease, Prof. Maor Sauler

Find out more and register

11–13 June, 2026
Skills course
Rigid bronchoscopy

11–13 June, 2026
Skills course
Rigid bronchoscopy

Panel discussion – Antimicrobial stewardship in TB 15 June, 2026 from 13:00–14:00 CEST This ERS/UNITE4TB webinar, chaired by Prof. Raquel Duarte and Prof. Christoph Lange, will enable participants to: Understand core antimicrobial stewardship principles in the context of TB prevention and care. Identify common stewardship challenges contributing to drug resistance in TB. Apply stewardship-informed strategies to optimise TB treatment selection and duration. Promote integrated AMS practices within clinical services and TB control programmes.

Find out more and register

16–19 June, 2026
Course
Academy of adult respiratory medicine

16–19 June, 2026
Course
Academy of paediatric respiratory medicine

Register now! Pleural infection 16 June, 2026 | 18:00–19:00 CEST

Dear colleagues, Registration is open for the next ERS Vision Live panel discussion, hosted exclusively on the ERS Respiratory Channel.   Taking place on 16 June, this instalment will see an expert panel discuss pleural infection.   The panellists will discuss key areas, including: A clinician’s perspective on the ERS/ESTS guidelines Challenges and controversies in treatment options Outcome prediction: biomarkers and future directions The event is completely free to access but registration is required. Learn more and register now Speakers: Dr John Corcoran John is a Consultant Respiratory Physician and Lung Cancer MDT lead in the Academic Department of Respiratory Medicine, Royal Devon University Healthcare NHS Foundation Trust, United Kingdom. He is a member of the guideline development group for the British Thoracic Society guideline for pleural disease, published in 2023, and maintains interest in pleural disease, lung cancer, and point-of-care thoracic ultrasound. Prof. Laura Gleeson Laura is Consultant Respiratory Physician in St James's Hospital, where she established the award-winning Ambulatory Pleural Effusion Service in 2024. She is Associate Professor of Respiratory Medicine in Trinity College, Dublin, Ireland where she leads the Respiratory Immunometabolism Research Group, focused on translational research in lung and pleural diseases. Dr Eva Polverino Eva is Head of the Research Unit in Respiratory Infections, Department of Respiratory Diseases at Hospital Vall d'Hebron in Barcelona, Spain. She has been a specialist in respiratory diseases since 2003 and is an active member of ERS. Prof. José Porcel José is Professor of Medicine at the University of Lleida and Head of the Department of Internal Medicine at Arnau de Vilanova University Hospital, Lleida, Spain. He has contributed to several international pleural disease guidelines and consensus statements, including the ERS/ESTS statement on the management of pleural infection in adults. Prof. Samira Shojaee Samira Shojaee is an Associate Professor of Medicine and Thoracic Surgery and the Director of the Pleural Disease Program at Vanderbilt University Medical Center. Her clinical areas of expertise include interventional pulmonology with a broad range of diagnostic, therapeutic and palliative airway and pleural procedures, lung cancer and pleural disease.

Virtual Pharmaceutical and Medical Device Pricing and Payment Transformation Summit
June 16-19, 2026

Covering Tariffs, Most Favored Nation, TrumpRX, Direct to Consumer, Direct to Employer, Role of CMS & CMMI: GENEROUS, GLOBE, GUARD & BALANCE Models, IRA Medicare Drug Price Negotiations, Price Reporting, FDA Regulation, Medicaid Rebates, Medicare Fair Price, 340B and PBMs

REGISTRATION: https://pharmapricingsummit.com/
AGENDA
TUITION SCHOLARSHIPS
PROMOTIONAL OPPORTUNITIES
ADMINISTRATION
Administration
Privacy
SPEAKING PROPOSALS
PAST EVENTS
CONTACT
HOME
KEYNOTE SPEAKERS

John Brooks, JD, MBA
(Invited)
Deputy Administrator and the Chief Policy and Regulatory Officer, CMS; Former Senior Advisor for Drug Pricing Reform to the Secretary of HHS; Former Health Policy Advisor, White House Domestic Policy Council (Trump), Washington, DC

Chris Klomp, MBA
(Invited)
Chief Counselor, US Department of Health and Human Services; Director of Medicare and Deputy Administrator, Centers for Medicare & Medicaid Services, Washington, DC

Liz Fowler, PhD, JD
Scholar, Johns Hopkins Bloomberg School of Public Health; Former Director, CMS CMMI (Biden); Former Special Assistant to President Obama, Washington, DC

Mark McClellan, MD, PhD
Director, Robert J Margolis Center for Health Policy, Medicine and Health Policy, Duke University; Former CMS Administrator and FDA Commissioner (GW Bush), Washington, DC

Nicholas Minter, MPP
Acting Director, Seamless Care Models Group, CMS Innovation Center; Former Senior Budget Analyst, HHS; Former Program Examiner, OMB, Silver Springs, MD

Mickey Morgan
Director, CMS Division of Pharmacy, Center for Medicaid and CHIP Services, Centers for Medicare and Medicaid Services, Washington, DC

Larisa Strawbridge, MPH
Acting Director, Medicare Drug Rebate and Negotiations Group, Centers for Medicare and Medicaid Services, Washington, DC

Abe Sutton, JD
(Invited)
Director, CMS Center for Medicare and Medicaid Innovation; Former Policy Advisor at the Domestic Policy Council, The White House (Trump), Washington, DC

FEATURING ROUNDTABLE ON THE IMPLICATIONS OF ACTUAL AND THREATENED US PHARMA TARIFFS BY

Neena Shenai, JD
Partner, WilmerHale; Former Chief Legal Counsel and Head of Compliance for Global Trade, Medtronic; Former Trade Counsel, Ways and Means Committee, US House of Representatives, Washington, DC

Mariana P. Socal, MD, PhD, MPP, MSc
Associate Professor, Bloomberg School of Public Health and Carey Business School, Johns Hopkins University; Co-author, “Comparative Approaches to Drug Pricing” and “Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains”, Baltimore, MD

Arun Venkataraman, MA, JD
Partner, Covington; Former Assistant Secretary of Commerce, US and Foreign Commercial Service, International Trade Administration; Former Counselor to the Secretary, US Department of Commerce, Washington, DC

Joshua M. Sharfstein, MD
Vice Dean, Johns Hopkins Bloomberg School of Public Health; Former Secretary, Maryland’s Health Department; Former Principal Deputy Commissioner, US FDA, Baltimore, MD (Moderator)

EARLY BIRD REGISTRATION EXPIRES MAY 29

Click here to register by May 29 for early bird registration discount.

AGENDA NOW AVAILABLE

Click here for current agenda.

SPECIAL PHARMACEUTICAL COMPLIANCE FORUM (PCF) REGISTRATION DISCOUNT

PCF member companies click here to register.

EXHIBIT & SPONSORSHIP OPPORTUNITIES

Click here for promotional opportunities.

PRODUCED BY

MEDIA PARTNERS

TUITION SCHOLARSHIPS

The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those in employment transition.

TARIFF COMPLIANCE ISSUES FOR PHARMACEUTICALS AND MEDICAL DEVICE COMPANIES BY

Shani Harmon Alexander, MS, JD
Senior Trade Counsel, Gilead; Former Director, Legal Manufacturing, Organon, Washington, DC

Galina Free, MSc
Head of Trade Compliance, Danaher; Former Global Tax and Customs, Cisco, Bellevue, WA

Roger McCrary, JD
Senior Trade Counsel, Becton Dickinson; Former Vice President of Global Compliance, Momentive; Former Global Trade Compliance Program Leader, Medtronic, Oakland, MI

Neena Shenai, JD
Partner, WilmerHale; Former Chief Legal Counsel and Head of Compliance for Global Trade, Medtronic; Former Trade Counsel, Ways and Means Committee, US House of Representatives, Washington, DC (Moderator)

AN OVERVIEW OF US PHARMA & DEVICE MOST FAVORED
NATIONS/INTERNATIONAL REFERENCE PRICING INITIATIVES BY

Lanhee Chen, PhD
Fellow, Hoover Institution, Stanford; Former Counselor, HHS; Author, “Alternatives to Government-Imposed Price Controls to Lower US Drug Prices”, Stanford, CA

Liz Fowler, PhD, JD
Scholar, Johns Hopkins Bloomberg School of Public Health; Former Director, CMS CMMI (Biden); Former Special Assistant to President Obama, Washington, DC

James Robinson, PhD
Schaeffer Professor of Health Economics & Director, Berkeley Center for Health Technology, University of California, Berkeley, CA

Ian Spatz, MPA, JD
Principal, Rock Creek Policy Group; Former Vice President, Public Policy, Merck, Author, “Most Favored Nation Drug Pricing: Aiming at Pharma’s Achilles Heel”, Washington, DC

Kristi Martin, MA, MPH
Founder, Highway 136 Consulting; Former Chief of Staff for Medicare, CMS; Former Health Care VP, Arnold Ventures, Washington, DC (Moderator)

IMPLEMENTING THE CMS/CMMI BALANCE, GENEROUS, GLOBE AND GUARD MODELS BY

Cindy Cerneka, MBA
Managing Director, Helio Health Group; Former Manager Government Reporting and Commercial Rebates, Mallinckrodt Pharmaceuticals, Durham, NC

Tracy Mumpower
Director Managed Services, Helio Health Group; Former Manager, Commercial Contract Administration, King Pharmaceuticals, Bristol, VA

Joseph Skupen, CPA
Managing Director, Senior Advisor and Technical Leader, Helio Health Group; Former Director FMV Tiering Global Medical Affairs, Sanofi, Berwyn, PA

Stephanie Trunk, JD, CPS
Partner and Life Sciences Industry Group Co-Leader, ArentFox Schiff; Former Legal Counsel, Catalyst Health Solutions, Washington, DC

Chris Cobourn, MS
Managing Director and Government Programs (GP) Practice Lead, Helio Health Group, Placida, FL (Moderator)

NEW BUSINESS MODELS TO MEET PATIENTS WHERE THEY ARE BY

Peter Brensilver, MPH, JD
Senior Vice President, Chief Global Commercial Compliance, and Risk Counsel, Pfizer, New York, NY

Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, LLP, Washington, DC

Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling, LLP; Former Attorney, US Federal Trade Commission, Washington, DC

HOW TO ENGAGE WITH GOVERNMENT’S DIRECT-TO-CONSUMER DRUG POLICY BY

Jennifer Bragg, JD
Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US Food and Drug Administration, Washington, DC

Sari Heller Ratican, JD, LLM
Privacy and Cybersecurity Counsel, Fenwick & West; Former Skills: FCRA, Chief Privacy Officer, Worldwide Compliance & Business Ethics, Amgen; Former Legislative Counsel, AMA, Los Angeles, CA

Jennifer Snow, MPH
Founder, Apteka Policy; Former Vice President, Market Economics, AmerisourceBergen; Former Advisor, Office of Health Insurance Exchanges, US Department of Health and Human Services, Washington, DC

Mary Kohler, JD
Founder and Principal, Kohler Health Law, PC; Former Expert Counsel, Worldwide Compliance & Business Ethics, Amgen; Former Assistant General Counsel, GSK, Los Angeles, CA (Moderator)

AND A BIO AND PhRMA UPDATE BY

John Delacourt, JD
Deputy General Counsel, Vice President Health, Regulatory & Commercial Operations, Biotechnology Innovation Organization; Former Chief Antitrust Counsel, Office of Policy Planning, FTC, Washington, DC

Julie Ritchie Wagner, JD
Senior Assistant General Counsel & Head of Global Ethics, Compliance & Enforcement Legal Policy, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Was

16–19 June, 2026
Course
Academy of adult respiratory medicine

16–19 June, 2026
Course
Academy of paediatric respiratory medicine

Virtual Pharmaceutical and Medical Device Pricing and Payment Transformation Summit
June 16-19, 2026

Covering Tariffs, Most Favored Nation, TrumpRX, Direct to Consumer, Direct to Employer, Role of CMS & CMMI: GENEROUS, GLOBE, GUARD & BALANCE Models, IRA Medicare Drug Price Negotiations, Price Reporting, FDA Regulation, Medicaid Rebates, Medicare Fair Price, 340B and PBMs

REGISTRATION: https://pharmapricingsummit.com/
AGENDA
TUITION SCHOLARSHIPS
PROMOTIONAL OPPORTUNITIES
ADMINISTRATION
Administration
Privacy
SPEAKING PROPOSALS
PAST EVENTS
CONTACT
HOME
KEYNOTE SPEAKERS

John Brooks, JD, MBA
(Invited)
Deputy Administrator and the Chief Policy and Regulatory Officer, CMS; Former Senior Advisor for Drug Pricing Reform to the Secretary of HHS; Former Health Policy Advisor, White House Domestic Policy Council (Trump), Washington, DC

Chris Klomp, MBA
(Invited)
Chief Counselor, US Department of Health and Human Services; Director of Medicare and Deputy Administrator, Centers for Medicare & Medicaid Services, Washington, DC

Liz Fowler, PhD, JD
Scholar, Johns Hopkins Bloomberg School of Public Health; Former Director, CMS CMMI (Biden); Former Special Assistant to President Obama, Washington, DC

Mark McClellan, MD, PhD
Director, Robert J Margolis Center for Health Policy, Medicine and Health Policy, Duke University; Former CMS Administrator and FDA Commissioner (GW Bush), Washington, DC

Nicholas Minter, MPP
Acting Director, Seamless Care Models Group, CMS Innovation Center; Former Senior Budget Analyst, HHS; Former Program Examiner, OMB, Silver Springs, MD

Mickey Morgan
Director, CMS Division of Pharmacy, Center for Medicaid and CHIP Services, Centers for Medicare and Medicaid Services, Washington, DC

Larisa Strawbridge, MPH
Acting Director, Medicare Drug Rebate and Negotiations Group, Centers for Medicare and Medicaid Services, Washington, DC

Abe Sutton, JD
(Invited)
Director, CMS Center for Medicare and Medicaid Innovation; Former Policy Advisor at the Domestic Policy Council, The White House (Trump), Washington, DC

FEATURING ROUNDTABLE ON THE IMPLICATIONS OF ACTUAL AND THREATENED US PHARMA TARIFFS BY

Neena Shenai, JD
Partner, WilmerHale; Former Chief Legal Counsel and Head of Compliance for Global Trade, Medtronic; Former Trade Counsel, Ways and Means Committee, US House of Representatives, Washington, DC

Mariana P. Socal, MD, PhD, MPP, MSc
Associate Professor, Bloomberg School of Public Health and Carey Business School, Johns Hopkins University; Co-author, “Comparative Approaches to Drug Pricing” and “Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains”, Baltimore, MD

Arun Venkataraman, MA, JD
Partner, Covington; Former Assistant Secretary of Commerce, US and Foreign Commercial Service, International Trade Administration; Former Counselor to the Secretary, US Department of Commerce, Washington, DC

Joshua M. Sharfstein, MD
Vice Dean, Johns Hopkins Bloomberg School of Public Health; Former Secretary, Maryland’s Health Department; Former Principal Deputy Commissioner, US FDA, Baltimore, MD (Moderator)

EARLY BIRD REGISTRATION EXPIRES MAY 29

Click here to register by May 29 for early bird registration discount.

AGENDA NOW AVAILABLE

Click here for current agenda.

SPECIAL PHARMACEUTICAL COMPLIANCE FORUM (PCF) REGISTRATION DISCOUNT

PCF member companies click here to register.

EXHIBIT & SPONSORSHIP OPPORTUNITIES

Click here for promotional opportunities.

PRODUCED BY

MEDIA PARTNERS

TUITION SCHOLARSHIPS

The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those in employment transition.

TARIFF COMPLIANCE ISSUES FOR PHARMACEUTICALS AND MEDICAL DEVICE COMPANIES BY

Shani Harmon Alexander, MS, JD
Senior Trade Counsel, Gilead; Former Director, Legal Manufacturing, Organon, Washington, DC

Galina Free, MSc
Head of Trade Compliance, Danaher; Former Global Tax and Customs, Cisco, Bellevue, WA

Roger McCrary, JD
Senior Trade Counsel, Becton Dickinson; Former Vice President of Global Compliance, Momentive; Former Global Trade Compliance Program Leader, Medtronic, Oakland, MI

Neena Shenai, JD
Partner, WilmerHale; Former Chief Legal Counsel and Head of Compliance for Global Trade, Medtronic; Former Trade Counsel, Ways and Means Committee, US House of Representatives, Washington, DC (Moderator)

AN OVERVIEW OF US PHARMA & DEVICE MOST FAVORED
NATIONS/INTERNATIONAL REFERENCE PRICING INITIATIVES BY

Lanhee Chen, PhD
Fellow, Hoover Institution, Stanford; Former Counselor, HHS; Author, “Alternatives to Government-Imposed Price Controls to Lower US Drug Prices”, Stanford, CA

Liz Fowler, PhD, JD
Scholar, Johns Hopkins Bloomberg School of Public Health; Former Director, CMS CMMI (Biden); Former Special Assistant to President Obama, Washington, DC

James Robinson, PhD
Schaeffer Professor of Health Economics & Director, Berkeley Center for Health Technology, University of California, Berkeley, CA

Ian Spatz, MPA, JD
Principal, Rock Creek Policy Group; Former Vice President, Public Policy, Merck, Author, “Most Favored Nation Drug Pricing: Aiming at Pharma’s Achilles Heel”, Washington, DC

Kristi Martin, MA, MPH
Founder, Highway 136 Consulting; Former Chief of Staff for Medicare, CMS; Former Health Care VP, Arnold Ventures, Washington, DC (Moderator)

IMPLEMENTING THE CMS/CMMI BALANCE, GENEROUS, GLOBE AND GUARD MODELS BY

Cindy Cerneka, MBA
Managing Director, Helio Health Group; Former Manager Government Reporting and Commercial Rebates, Mallinckrodt Pharmaceuticals, Durham, NC

Tracy Mumpower
Director Managed Services, Helio Health Group; Former Manager, Commercial Contract Administration, King Pharmaceuticals, Bristol, VA

Joseph Skupen, CPA
Managing Director, Senior Advisor and Technical Leader, Helio Health Group; Former Director FMV Tiering Global Medical Affairs, Sanofi, Berwyn, PA

Stephanie Trunk, JD, CPS
Partner and Life Sciences Industry Group Co-Leader, ArentFox Schiff; Former Legal Counsel, Catalyst Health Solutions, Washington, DC

Chris Cobourn, MS
Managing Director and Government Programs (GP) Practice Lead, Helio Health Group, Placida, FL (Moderator)

NEW BUSINESS MODELS TO MEET PATIENTS WHERE THEY ARE BY

Peter Brensilver, MPH, JD
Senior Vice President, Chief Global Commercial Compliance, and Risk Counsel, Pfizer, New York, NY

Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, LLP, Washington, DC

Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling, LLP; Former Attorney, US Federal Trade Commission, Washington, DC

HOW TO ENGAGE WITH GOVERNMENT’S DIRECT-TO-CONSUMER DRUG POLICY BY

Jennifer Bragg, JD
Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US Food and Drug Administration, Washington, DC

Sari Heller Ratican, JD, LLM
Privacy and Cybersecurity Counsel, Fenwick & West; Former Skills: FCRA, Chief Privacy Officer, Worldwide Compliance & Business Ethics, Amgen; Former Legislative Counsel, AMA, Los Angeles, CA

Jennifer Snow, MPH
Founder, Apteka Policy; Former Vice President, Market Economics, AmerisourceBergen; Former Advisor, Office of Health Insurance Exchanges, US Department of Health and Human Services, Washington, DC

Mary Kohler, JD
Founder and Principal, Kohler Health Law, PC; Former Expert Counsel, Worldwide Compliance & Business Ethics, Amgen; Former Assistant General Counsel, GSK, Los Angeles, CA (Moderator)

AND A BIO AND PhRMA UPDATE BY

John Delacourt, JD
Deputy General Counsel, Vice President Health, Regulatory & Commercial Operations, Biotechnology Innovation Organization; Former Chief Antitrust Counsel, Office of Policy Planning, FTC, Washington, DC

Julie Ritchie Wagner, JD
Senior Assistant General Counsel & Head of Global Ethics, Compliance & Enforcement Legal Policy, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Was

16–19 June, 2026
Course
Academy of adult respiratory medicine

16–19 June, 2026
Course
Academy of paediatric respiratory medicine

Virtual Pharmaceutical and Medical Device Pricing and Payment Transformation Summit
June 16-19, 2026

Covering Tariffs, Most Favored Nation, TrumpRX, Direct to Consumer, Direct to Employer, Role of CMS & CMMI: GENEROUS, GLOBE, GUARD & BALANCE Models, IRA Medicare Drug Price Negotiations, Price Reporting, FDA Regulation, Medicaid Rebates, Medicare Fair Price, 340B and PBMs

REGISTRATION: https://pharmapricingsummit.com/
AGENDA
TUITION SCHOLARSHIPS
PROMOTIONAL OPPORTUNITIES
ADMINISTRATION
Administration
Privacy
SPEAKING PROPOSALS
PAST EVENTS
CONTACT
HOME
KEYNOTE SPEAKERS

John Brooks, JD, MBA
(Invited)
Deputy Administrator and the Chief Policy and Regulatory Officer, CMS; Former Senior Advisor for Drug Pricing Reform to the Secretary of HHS; Former Health Policy Advisor, White House Domestic Policy Council (Trump), Washington, DC

Chris Klomp, MBA
(Invited)
Chief Counselor, US Department of Health and Human Services; Director of Medicare and Deputy Administrator, Centers for Medicare & Medicaid Services, Washington, DC

Liz Fowler, PhD, JD
Scholar, Johns Hopkins Bloomberg School of Public Health; Former Director, CMS CMMI (Biden); Former Special Assistant to President Obama, Washington, DC

Mark McClellan, MD, PhD
Director, Robert J Margolis Center for Health Policy, Medicine and Health Policy, Duke University; Former CMS Administrator and FDA Commissioner (GW Bush), Washington, DC

Nicholas Minter, MPP
Acting Director, Seamless Care Models Group, CMS Innovation Center; Former Senior Budget Analyst, HHS; Former Program Examiner, OMB, Silver Springs, MD

Mickey Morgan
Director, CMS Division of Pharmacy, Center for Medicaid and CHIP Services, Centers for Medicare and Medicaid Services, Washington, DC

Larisa Strawbridge, MPH
Acting Director, Medicare Drug Rebate and Negotiations Group, Centers for Medicare and Medicaid Services, Washington, DC

Abe Sutton, JD
(Invited)
Director, CMS Center for Medicare and Medicaid Innovation; Former Policy Advisor at the Domestic Policy Council, The White House (Trump), Washington, DC

FEATURING ROUNDTABLE ON THE IMPLICATIONS OF ACTUAL AND THREATENED US PHARMA TARIFFS BY

Neena Shenai, JD
Partner, WilmerHale; Former Chief Legal Counsel and Head of Compliance for Global Trade, Medtronic; Former Trade Counsel, Ways and Means Committee, US House of Representatives, Washington, DC

Mariana P. Socal, MD, PhD, MPP, MSc
Associate Professor, Bloomberg School of Public Health and Carey Business School, Johns Hopkins University; Co-author, “Comparative Approaches to Drug Pricing” and “Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains”, Baltimore, MD

Arun Venkataraman, MA, JD
Partner, Covington; Former Assistant Secretary of Commerce, US and Foreign Commercial Service, International Trade Administration; Former Counselor to the Secretary, US Department of Commerce, Washington, DC

Joshua M. Sharfstein, MD
Vice Dean, Johns Hopkins Bloomberg School of Public Health; Former Secretary, Maryland’s Health Department; Former Principal Deputy Commissioner, US FDA, Baltimore, MD (Moderator)

EARLY BIRD REGISTRATION EXPIRES MAY 29

Click here to register by May 29 for early bird registration discount.

AGENDA NOW AVAILABLE

Click here for current agenda.

SPECIAL PHARMACEUTICAL COMPLIANCE FORUM (PCF) REGISTRATION DISCOUNT

PCF member companies click here to register.

EXHIBIT & SPONSORSHIP OPPORTUNITIES

Click here for promotional opportunities.

PRODUCED BY

MEDIA PARTNERS

TUITION SCHOLARSHIPS

The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those in employment transition.

TARIFF COMPLIANCE ISSUES FOR PHARMACEUTICALS AND MEDICAL DEVICE COMPANIES BY

Shani Harmon Alexander, MS, JD
Senior Trade Counsel, Gilead; Former Director, Legal Manufacturing, Organon, Washington, DC

Galina Free, MSc
Head of Trade Compliance, Danaher; Former Global Tax and Customs, Cisco, Bellevue, WA

Roger McCrary, JD
Senior Trade Counsel, Becton Dickinson; Former Vice President of Global Compliance, Momentive; Former Global Trade Compliance Program Leader, Medtronic, Oakland, MI

Neena Shenai, JD
Partner, WilmerHale; Former Chief Legal Counsel and Head of Compliance for Global Trade, Medtronic; Former Trade Counsel, Ways and Means Committee, US House of Representatives, Washington, DC (Moderator)

AN OVERVIEW OF US PHARMA & DEVICE MOST FAVORED
NATIONS/INTERNATIONAL REFERENCE PRICING INITIATIVES BY

Lanhee Chen, PhD
Fellow, Hoover Institution, Stanford; Former Counselor, HHS; Author, “Alternatives to Government-Imposed Price Controls to Lower US Drug Prices”, Stanford, CA

Liz Fowler, PhD, JD
Scholar, Johns Hopkins Bloomberg School of Public Health; Former Director, CMS CMMI (Biden); Former Special Assistant to President Obama, Washington, DC

James Robinson, PhD
Schaeffer Professor of Health Economics & Director, Berkeley Center for Health Technology, University of California, Berkeley, CA

Ian Spatz, MPA, JD
Principal, Rock Creek Policy Group; Former Vice President, Public Policy, Merck, Author, “Most Favored Nation Drug Pricing: Aiming at Pharma’s Achilles Heel”, Washington, DC

Kristi Martin, MA, MPH
Founder, Highway 136 Consulting; Former Chief of Staff for Medicare, CMS; Former Health Care VP, Arnold Ventures, Washington, DC (Moderator)

IMPLEMENTING THE CMS/CMMI BALANCE, GENEROUS, GLOBE AND GUARD MODELS BY

Cindy Cerneka, MBA
Managing Director, Helio Health Group; Former Manager Government Reporting and Commercial Rebates, Mallinckrodt Pharmaceuticals, Durham, NC

Tracy Mumpower
Director Managed Services, Helio Health Group; Former Manager, Commercial Contract Administration, King Pharmaceuticals, Bristol, VA

Joseph Skupen, CPA
Managing Director, Senior Advisor and Technical Leader, Helio Health Group; Former Director FMV Tiering Global Medical Affairs, Sanofi, Berwyn, PA

Stephanie Trunk, JD, CPS
Partner and Life Sciences Industry Group Co-Leader, ArentFox Schiff; Former Legal Counsel, Catalyst Health Solutions, Washington, DC

Chris Cobourn, MS
Managing Director and Government Programs (GP) Practice Lead, Helio Health Group, Placida, FL (Moderator)

NEW BUSINESS MODELS TO MEET PATIENTS WHERE THEY ARE BY

Peter Brensilver, MPH, JD
Senior Vice President, Chief Global Commercial Compliance, and Risk Counsel, Pfizer, New York, NY

Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, LLP, Washington, DC

Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling, LLP; Former Attorney, US Federal Trade Commission, Washington, DC

HOW TO ENGAGE WITH GOVERNMENT’S DIRECT-TO-CONSUMER DRUG POLICY BY

Jennifer Bragg, JD
Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US Food and Drug Administration, Washington, DC

Sari Heller Ratican, JD, LLM
Privacy and Cybersecurity Counsel, Fenwick & West; Former Skills: FCRA, Chief Privacy Officer, Worldwide Compliance & Business Ethics, Amgen; Former Legislative Counsel, AMA, Los Angeles, CA

Jennifer Snow, MPH
Founder, Apteka Policy; Former Vice President, Market Economics, AmerisourceBergen; Former Advisor, Office of Health Insurance Exchanges, US Department of Health and Human Services, Washington, DC

Mary Kohler, JD
Founder and Principal, Kohler Health Law, PC; Former Expert Counsel, Worldwide Compliance & Business Ethics, Amgen; Former Assistant General Counsel, GSK, Los Angeles, CA (Moderator)

AND A BIO AND PhRMA UPDATE BY

John Delacourt, JD
Deputy General Counsel, Vice President Health, Regulatory & Commercial Operations, Biotechnology Innovation Organization; Former Chief Antitrust Counsel, Office of Policy Planning, FTC, Washington, DC

Julie Ritchie Wagner, JD
Senior Assistant General Counsel & Head of Global Ethics, Compliance & Enforcement Legal Policy, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Was

16–19 June, 2026
Course
Academy of adult respiratory medicine

16–19 June, 2026
Course
Academy of paediatric respiratory medicine

Virtual Pharmaceutical and Medical Device Pricing and Payment Transformation Summit
June 16-19, 2026

Covering Tariffs, Most Favored Nation, TrumpRX, Direct to Consumer, Direct to Employer, Role of CMS & CMMI: GENEROUS, GLOBE, GUARD & BALANCE Models, IRA Medicare Drug Price Negotiations, Price Reporting, FDA Regulation, Medicaid Rebates, Medicare Fair Price, 340B and PBMs

REGISTRATION: https://pharmapricingsummit.com/
AGENDA
TUITION SCHOLARSHIPS
PROMOTIONAL OPPORTUNITIES
ADMINISTRATION
Administration
Privacy
SPEAKING PROPOSALS
PAST EVENTS
CONTACT
HOME
KEYNOTE SPEAKERS

John Brooks, JD, MBA
(Invited)
Deputy Administrator and the Chief Policy and Regulatory Officer, CMS; Former Senior Advisor for Drug Pricing Reform to the Secretary of HHS; Former Health Policy Advisor, White House Domestic Policy Council (Trump), Washington, DC

Chris Klomp, MBA
(Invited)
Chief Counselor, US Department of Health and Human Services; Director of Medicare and Deputy Administrator, Centers for Medicare & Medicaid Services, Washington, DC

Liz Fowler, PhD, JD
Scholar, Johns Hopkins Bloomberg School of Public Health; Former Director, CMS CMMI (Biden); Former Special Assistant to President Obama, Washington, DC

Mark McClellan, MD, PhD
Director, Robert J Margolis Center for Health Policy, Medicine and Health Policy, Duke University; Former CMS Administrator and FDA Commissioner (GW Bush), Washington, DC

Nicholas Minter, MPP
Acting Director, Seamless Care Models Group, CMS Innovation Center; Former Senior Budget Analyst, HHS; Former Program Examiner, OMB, Silver Springs, MD

Mickey Morgan
Director, CMS Division of Pharmacy, Center for Medicaid and CHIP Services, Centers for Medicare and Medicaid Services, Washington, DC

Larisa Strawbridge, MPH
Acting Director, Medicare Drug Rebate and Negotiations Group, Centers for Medicare and Medicaid Services, Washington, DC

Abe Sutton, JD
(Invited)
Director, CMS Center for Medicare and Medicaid Innovation; Former Policy Advisor at the Domestic Policy Council, The White House (Trump), Washington, DC

FEATURING ROUNDTABLE ON THE IMPLICATIONS OF ACTUAL AND THREATENED US PHARMA TARIFFS BY

Neena Shenai, JD
Partner, WilmerHale; Former Chief Legal Counsel and Head of Compliance for Global Trade, Medtronic; Former Trade Counsel, Ways and Means Committee, US House of Representatives, Washington, DC

Mariana P. Socal, MD, PhD, MPP, MSc
Associate Professor, Bloomberg School of Public Health and Carey Business School, Johns Hopkins University; Co-author, “Comparative Approaches to Drug Pricing” and “Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains”, Baltimore, MD

Arun Venkataraman, MA, JD
Partner, Covington; Former Assistant Secretary of Commerce, US and Foreign Commercial Service, International Trade Administration; Former Counselor to the Secretary, US Department of Commerce, Washington, DC

Joshua M. Sharfstein, MD
Vice Dean, Johns Hopkins Bloomberg School of Public Health; Former Secretary, Maryland’s Health Department; Former Principal Deputy Commissioner, US FDA, Baltimore, MD (Moderator)

EARLY BIRD REGISTRATION EXPIRES MAY 29

Click here to register by May 29 for early bird registration discount.

AGENDA NOW AVAILABLE

Click here for current agenda.

SPECIAL PHARMACEUTICAL COMPLIANCE FORUM (PCF) REGISTRATION DISCOUNT

PCF member companies click here to register.

EXHIBIT & SPONSORSHIP OPPORTUNITIES

Click here for promotional opportunities.

PRODUCED BY

MEDIA PARTNERS

TUITION SCHOLARSHIPS

The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those in employment transition.

TARIFF COMPLIANCE ISSUES FOR PHARMACEUTICALS AND MEDICAL DEVICE COMPANIES BY

Shani Harmon Alexander, MS, JD
Senior Trade Counsel, Gilead; Former Director, Legal Manufacturing, Organon, Washington, DC

Galina Free, MSc
Head of Trade Compliance, Danaher; Former Global Tax and Customs, Cisco, Bellevue, WA

Roger McCrary, JD
Senior Trade Counsel, Becton Dickinson; Former Vice President of Global Compliance, Momentive; Former Global Trade Compliance Program Leader, Medtronic, Oakland, MI

Neena Shenai, JD
Partner, WilmerHale; Former Chief Legal Counsel and Head of Compliance for Global Trade, Medtronic; Former Trade Counsel, Ways and Means Committee, US House of Representatives, Washington, DC (Moderator)

AN OVERVIEW OF US PHARMA & DEVICE MOST FAVORED
NATIONS/INTERNATIONAL REFERENCE PRICING INITIATIVES BY

Lanhee Chen, PhD
Fellow, Hoover Institution, Stanford; Former Counselor, HHS; Author, “Alternatives to Government-Imposed Price Controls to Lower US Drug Prices”, Stanford, CA

Liz Fowler, PhD, JD
Scholar, Johns Hopkins Bloomberg School of Public Health; Former Director, CMS CMMI (Biden); Former Special Assistant to President Obama, Washington, DC

James Robinson, PhD
Schaeffer Professor of Health Economics & Director, Berkeley Center for Health Technology, University of California, Berkeley, CA

Ian Spatz, MPA, JD
Principal, Rock Creek Policy Group; Former Vice President, Public Policy, Merck, Author, “Most Favored Nation Drug Pricing: Aiming at Pharma’s Achilles Heel”, Washington, DC

Kristi Martin, MA, MPH
Founder, Highway 136 Consulting; Former Chief of Staff for Medicare, CMS; Former Health Care VP, Arnold Ventures, Washington, DC (Moderator)

IMPLEMENTING THE CMS/CMMI BALANCE, GENEROUS, GLOBE AND GUARD MODELS BY

Cindy Cerneka, MBA
Managing Director, Helio Health Group; Former Manager Government Reporting and Commercial Rebates, Mallinckrodt Pharmaceuticals, Durham, NC

Tracy Mumpower
Director Managed Services, Helio Health Group; Former Manager, Commercial Contract Administration, King Pharmaceuticals, Bristol, VA

Joseph Skupen, CPA
Managing Director, Senior Advisor and Technical Leader, Helio Health Group; Former Director FMV Tiering Global Medical Affairs, Sanofi, Berwyn, PA

Stephanie Trunk, JD, CPS
Partner and Life Sciences Industry Group Co-Leader, ArentFox Schiff; Former Legal Counsel, Catalyst Health Solutions, Washington, DC

Chris Cobourn, MS
Managing Director and Government Programs (GP) Practice Lead, Helio Health Group, Placida, FL (Moderator)

NEW BUSINESS MODELS TO MEET PATIENTS WHERE THEY ARE BY

Peter Brensilver, MPH, JD
Senior Vice President, Chief Global Commercial Compliance, and Risk Counsel, Pfizer, New York, NY

Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, LLP, Washington, DC

Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling, LLP; Former Attorney, US Federal Trade Commission, Washington, DC

HOW TO ENGAGE WITH GOVERNMENT’S DIRECT-TO-CONSUMER DRUG POLICY BY

Jennifer Bragg, JD
Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US Food and Drug Administration, Washington, DC

Sari Heller Ratican, JD, LLM
Privacy and Cybersecurity Counsel, Fenwick & West; Former Skills: FCRA, Chief Privacy Officer, Worldwide Compliance & Business Ethics, Amgen; Former Legislative Counsel, AMA, Los Angeles, CA

Jennifer Snow, MPH
Founder, Apteka Policy; Former Vice President, Market Economics, AmerisourceBergen; Former Advisor, Office of Health Insurance Exchanges, US Department of Health and Human Services, Washington, DC

Mary Kohler, JD
Founder and Principal, Kohler Health Law, PC; Former Expert Counsel, Worldwide Compliance & Business Ethics, Amgen; Former Assistant General Counsel, GSK, Los Angeles, CA (Moderator)

AND A BIO AND PhRMA UPDATE BY

John Delacourt, JD
Deputy General Counsel, Vice President Health, Regulatory & Commercial Operations, Biotechnology Innovation Organization; Former Chief Antitrust Counsel, Office of Policy Planning, FTC, Washington, DC

Julie Ritchie Wagner, JD
Senior Assistant General Counsel & Head of Global Ethics, Compliance & Enforcement Legal Policy, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Was

Panel discussion on artificial intelligence and digital tools in paediatric asthma 23 June, 2026 from 17:00–18:00 CEST This ERS webinar, chaired by Dr Olena Gruzieva and Dr David Lo, will cover: AI in diagnostic imaging: utilising machine learning to detect structural airway changes and phenotype severe asthma (HRCT analysis). Digital biomarkers and prediction: harnessing data from smart devices (inhalers, wearables) to predict asthma attacks. Supported self-management: the role of AI-driven personalised feedback in improving medication adherence in children. From code to clinic: overcoming barriers to implementing AI tools in routine paediatric respiratory care.

Find out more and register

Tuesday, June 23, 2026 | Optimizing Patient Outcomes

From Mutation to Treatment: Understanding the Impact of New Targeted Therapies in Central Nervous System Cancers

CME-Register-button

• Virtual

Changing Innovation Paradigms — A Navigator’s Guide

about STAT Brand Studio and for your next event!

Where

Virtual

When

Tuesday, June 23, 2026
12:30 p.m. - 1:00 p.m. CDT

About

The innovation landscape has shifted, presenting both risk and opportunity. What does the rise in licensing deals from China signal about future breakthroughs? How is AI transforming both the pipeline and the way development is done? When it’s time to scale and the stakes are high, what can be done to de-risk and ensure smooth technology transfer?

Join senior executives, live from the BIO International Convention, as they explore what it takes to move from molecule to market in 2026.

Register below to join virtually for this live event. To join us in person, head to booth 2027 at the BIO International Convention. Please note there is limited in-person availability, so it is first-come, first-served. 

The listed time reflects your local time; this event runs 10:30-11:00 a.m. PT.

Moderator

Jesse McQuarters, Branded Content Editor at STAT

Speakers

Murray McCutcheon, SVP, Partnering, AbCellera

Murray is SVP of Partnering and part of the executive leadership team at AbCellera. He previously held BD and strategy roles at Harvard’s Office of Technology Development and Lux Research. He has a PhD in Physics from UBC, was a postdoctoral fellow at Harvard, and earned a BA from Oxford University as a Rhodes Scholar.

Pierre-Alain Ruffieux, Group Executive, Bioprocess, Cytiva

As Group Executive, Pierre‑Alain Ruffieux leads Cytiva’s bioprocessing businesses, accelerating the development of therapeutics from discovery to delivery. Formerly the CEO of Lonza Group, his 25-year career spans senior and c-suite technical development, quality and operations roles at Merck-Serono, Novartis and Roche.

Aimee Wang, Co-founder & CEO, CATUG Biotechnology

CATUG is a global RNA-LNP CRDMO platform enabling next-generation nucleic acid therapeutics. Since founding the company in 2021, Dr. Wang has led CATUG to become one of the leading RNA-LNP CRDMO platforms originating from China, serving over 400 biotechnology and pharmaceutical companies across the US, Europe, and Asia.

Register Now

Wednesday, June 24, 2026 | Case-based Workshop

Elevating CLL/SLL Management to Align Community Practice With Clinical Guidelines, Evidence-Based Data, and Shared Decisions
Provided by NCCN in collaboration with Decera Clinical Education.

CME-Register-button

25 June, 2026
Webinar
ERS/UNITE4TB webinar series: session two

Policy Webinar: Innovations in Cancer Care Through the Ages Virtual Attendance  June 25, 2026

Register

Policy Webinar: Innovations in Cancer Care Through the Ages Virtual Attendance  June 25, 2026

Register

The Data Revolution and Population Health: Tech Tools, Cross-Sector Data, and Community Expertise

Join this workshop online or in-person to explore how evolving technologies are transforming the collection, analysis, sharing, and use of multi-sector data relevant to improving population health. The event will take place on June 25.

Register now The National Academies’ Roundtable on Population Health Improvement is hosting a workshop to examine how advances such as AI and machine learning, advanced statistics, and crowdsourcing are transforming how data informs the work of improving the vital conditions for health and well-being.    Participants will consider key challenges and emerging solutions, including how to integrate data across sectors, and ensure that data systems are responsive to the needs of those who produce and use them.   Speakers and participants of the workshop will also: Highlight newer data sources proving to be most promising for population health assessments Assess ways to facilitate a greater yield from these resources Showcase tools that allow communities to engage in the creation, integration with, synthesizing and curation of data Explore needed partnerships for tools to be effective, safe, and secure Discuss intentions, accessibility, and responsibility behind newer data source creation, governance, and data silos